Common stock warrant issued to PHP to purchase up to 6,824,712 shares at $3.48 per share, vesting in tranches on market capitalization targets
| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
William Duke, Jr.
Chief Financial Officer and principal executive officer
|
53 | Not stated | Not stated | $2,141,222 | |
|
Marc Elia
Also a director
Chief Executive Officer
Title from the Form 8-K dated Aug 30, 2026
|
50 | Not stated | Not stated | Not reported | |
|
Robert Allen
Chief Scientific Officer
|
57 |
Since 2023
3 years
|
Not stated | Not reported | |
|
Jill Andersen
Chief Legal Officer and Corporate Secretary
|
53 |
Since 2021
5 years
|
Not stated | $2,486,155 | |
|
Julie Green
Chief Human Resources Officer
|
51 |
Since 2024
2 years
|
2022 | Not reported | |
|
Timothy Lee
Chief Commercial Officer
|
52 |
Since 2024
2 years
|
Not stated | $2,095,311 | |
|
Michael Mina
CMO and Chief Epidemiologist
Title from the Form 3 dated Jul 31, 2026
|
Not stated | Not stated | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 6, 2026 · updated by the 8-K of Sep 1, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Marc Elia
Board chair
|
50 |
2022
4 years
|
Independent | None stated | Fractyl Health, Inc. | $125,960 | |
|
Ajay Royan
Lead independent director
|
46 |
2020
6 years
|
Independent |
Nominating and Corporate Governance Committee · Chair
|
Fractyl Health, Inc. | $110,162 | |
|
Tamsin Berry
|
45 |
2022
4 years
|
Independent |
Audit Committee
|
None stated | $87,960 | |
|
Paul B. Bolno, M.D.
|
52 |
2025
1 year
|
Independent |
Compensation Committee
|
Wave Life Sciences Ltd. | $134,351 | |
|
Terrance McGuire
|
70 |
2020
6 years
|
Independent | None stated | Seer, Inc. | $84,460 | |
|
Kevin F. McLaughlin
|
69 |
2024
2 years
|
Independent |
Audit Committee
|
Vericel Corporation | $101,614 | |
|
Ian Sheffield
Joined Aug 30, 2026
|
- | - | - |
Compensation Committee
Audit Committee
|
- | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Common stock warrant issued to PHP to purchase up to 6,824,712 shares at $3.48 per share, vesting in tranches on market capitalization targets
Master Services Agreement and related work order with PHP, in connection with which the PHP Warrant was issued
Assignment and License Agreement under which we issued 5,000,000 shares of Series A preferred stock to Adimab in consideration for assigned rights and license
Payments to Adimab in connection with the Adimab Assignment Agreement
Royalty payments to Adimab under the Adimab Assignment Agreement
Payments to Adimab under the Adimab Collaboration Agreement (quarterly fees, research and option fees)
Upfront consideration paid to Adimab for rights under the Platform Transfer Agreement
Annual Fee payments to Adimab under the Platform Transfer Agreement
Payments to Adimab under the DNA Sequencing Services Agreement
LCMS Services Agreement with Adimab for molecular weight determination services; no payments made in the period
Loading...